Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Obinutuzumab 1g/40ml solution for infusion vials
0802030G0AAAAAA
|
Obinutuzumab | Obinutuzumab | Malignant Disease and Immunosuppression | No data available |
|
Octreotide 50micrograms/1ml solution for injection vials
0803043N0AAAKAK
|
Octreotide acetate | Octreotide acetate | Malignant Disease and Immunosuppression | No data available |
|
Ofatumumab 20mg/0.4ml inj pre-filled disposable devices
0802040BDAAAAAA
|
Ofatumumab | Ofatumumab | Malignant Disease and Immunosuppression | No data available |
|
Ofev 100mg capsules
0801050BTBCAAAA
|
Ofev | Nintedanib | Malignant Disease and Immunosuppression | No data available |
|
Ogivri 150mg pdr for concentrate for inf vials
0801050ADBIABAA
|
Ogivri | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Ogivri 420mg pdr for concentrate for inf vials
0801050ADBIAAAE
|
Ogivri | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Olaparib 100mg tablets
0801050BYAAABAB
|
Olaparib | Olaparib | Malignant Disease and Immunosuppression | No data available |
|
Olaparib 150mg tablets
0801050BYAAACAC
|
Olaparib | Olaparib | Malignant Disease and Immunosuppression | No data available |
|
Olaparib 50mg capsules
0801050BYAAAAAA
|
Olaparib | Olaparib | Malignant Disease and Immunosuppression | No data available |
|
Olatuton 10mg inj vials
0803043N0BCAAAE
|
Olatuton | Octreotide acetate | Malignant Disease and Immunosuppression | No data available |
|
Oncaspar 3,750unit powder for solution for injection vials
0801050BABBACAB
|
Oncaspar | Pegaspargase | Malignant Disease and Immunosuppression | No data available |
|
Oncaspar 3,750units/5ml inj vials (Imported)
0801050BABBAAAA
|
Oncaspar | Pegaspargase | Malignant Disease and Immunosuppression | No data available |
|
Oncaspar 3,750units/5ml solution for injection vials
0801050BABBABAA
|
Oncaspar | Pegaspargase | Malignant Disease and Immunosuppression | No data available |
|
OncoTICE 12.5mg instil vials
0802040X0BBAAAA
|
OncoTICE | Bacillus calmette-guerin (B.C.G.) | Malignant Disease and Immunosuppression | No data available |
|
Oncovin 1mg/1ml solution for injection vials
0801040M0BBADAE
|
Oncovin | Vincristine sulfate | Malignant Disease and Immunosuppression | No data available |
|
Onivyde pegylated liposomal 43mg/10ml concentrate for inf
0801050Q0BCAAAE
|
Onivyde | Irinotecan hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Onkotrone 20mg/10ml solution for infusion vials
0801020R0BCAAAA
|
Onkotrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Onkotrone 25mg/12.5ml solution for infusion vials
0801020R0BCABAB
|
Onkotrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Ontruzant 150mg pdr for concentrate for inf vials
0801050ADBDAAAA
|
Ontruzant | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Opdivo 100mg/10ml concentrate for inf vials
0802040ATBBABAB
|
Opdivo (old) | Nivolumab (old) | Malignant Disease and Immunosuppression | No data available |
|
Opdivo 240mg/24ml concentrate for inf vials
0802040ATBBACAC
|
Opdivo (old) | Nivolumab (old) | Malignant Disease and Immunosuppression | No data available |
|
Opdivo 40mg/4ml concentrate for solution for infusion vials
0802040ATBBAAAA
|
Opdivo (old) | Nivolumab (old) | Malignant Disease and Immunosuppression | No data available |
|
Orimeten 250mg tablets
0803041A0BBAAAA
|
Orimeten | Aminoglutethimide | Malignant Disease and Immunosuppression | No data available |
|
Osimertinib 40mg tablets
0801050CGAAAAAA
|
Osimertinib | Osimertinib | Malignant Disease and Immunosuppression | No data available |
|
Oxaliplatin 100mg powder for solution for infusion vials
0801050ALAAADAD
|
Oxaliplatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.